Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis.
Adult
Betacoronavirus
/ isolation & purification
Biomarkers
/ analysis
Blood Glucose
/ analysis
COVID-19
Cohort Studies
Coronavirus Infections
/ epidemiology
Diabetes Mellitus, Type 2
/ epidemiology
Female
Follow-Up Studies
Glycated Hemoglobin
/ analysis
Humans
Male
Middle Aged
Pandemics
Pneumonia, Viral
/ epidemiology
Prognosis
Risk Factors
SARS-CoV-2
Lockdown
Risk factor
Type 2 diabetes
Weight
Journal
Diabetes & metabolic syndrome
ISSN: 1878-0334
Titre abrégé: Diabetes Metab Syndr
Pays: Netherlands
ID NLM: 101462250
Informations de publication
Date de publication:
Historique:
received:
09
06
2020
revised:
10
06
2020
accepted:
10
06
2020
pubmed:
1
7
2020
medline:
29
9
2020
entrez:
1
7
2020
Statut:
ppublish
Résumé
Lockdown due to the Coronavirus disease 2019 (COVID 19) pandemic may cause weight gain and enhance the risk of type 2 diabetes mellitus (T2DM). We aimed to determine this risk in apparently non-diabetic individuals. Baseline demographic and clinical data from 100 apparently non-diabetic household members (related or unrelated) of patients with type 2 diabetes mellitus were collected until 49 days of lockdown and analyzed using the XL-STAT statistical software. A two-pronged analytical strategy was employed. First, the metabolic risk profile related to age, sex, weight, family history, and exercise pattern was analyzed. This was followed by an assessment of the risk of developing type 2 diabetes using an established risk assessment engine. There was a trend towards weight gain seen in 40% of the cohort, with 16% of the population experiencing a 2.1-5 kg weight increment. When all the risk parameters were analyzed together using the ADA risk engine, there was an increase in the ADA diabetes risk score in 7% of the population, with 6.66% in the high-risk group. There was a further increase in weight among 3% of the population who were already obese at baseline. We show an increased risk of T2MD consequent to weight gain during 49 days of lockdown in India.
Identifiants
pubmed: 32604013
pii: S1871-4021(20)30189-2
doi: 10.1016/j.dsx.2020.06.020
pmc: PMC7303633
pii:
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Glycated Hemoglobin A
0
hemoglobin A1c protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
949-952Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest None to declare.
Références
Ann Intern Med. 2009 Dec 1;151(11):775-83
pubmed: 19949143
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
Int J Surg. 2020 Jun;78:185-193
pubmed: 32305533
Am J Epidemiol. 1997 Aug 1;146(3):214-22
pubmed: 9247005
Obes Facts. 2020;13(2):292-296
pubmed: 32340020
Int J Environ Res Public Health. 2020 Mar 31;17(7):
pubmed: 32244498
Curr Diabetes Rev. 2017;13(1):65-80
pubmed: 27515855
Lancet Diabetes Endocrinol. 2015 Dec;3(12):1004-16
pubmed: 26489808
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):319-323
pubmed: 32298984
Obesity (Silver Spring). 2020 Jun;28(6):1008-1009
pubmed: 32227671
J Epidemiol Community Health. 2000 Aug;54(8):596-602
pubmed: 10890871
Int J Endocrinol. 2016;2016:1216783
pubmed: 27766104
Sci Total Environ. 2020 Jul 10;725:138539
pubmed: 32304973
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
Biomed Pharmacother. 2020 Jul;127:110195
pubmed: 32361161
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):917-920
pubmed: 32574982
Lancet Diabetes Endocrinol. 2018 Dec;6(12):979-991
pubmed: 30287103